Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study
Author:
Funder
UCB Pharma
Publisher
Elsevier BV
Subject
Clinical Neurology,Neurology
Reference21 articles.
1. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures;Ben-Menachem;Epilepsia,2007
2. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials;Biton;Epilepsy Behav.,2015
3. Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: saliva as a surrogate of pharmacokinetics in the central compartment;Cawello;Epilepsia,2013
4. Advances in epilepsy treatment: lacosamide pharmacokinetic profile;Cawello;Ann. N. Y. Acad. Sci.,2014
5. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese;Cheung;Epilepsia,2013
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis;CNS Drugs;2023-08-17
2. Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study;Frontiers in Pharmacology;2023-08-09
3. Quantifying and controlling the impact of regression to the mean on randomized controlled trials in epilepsy;Epilepsia;2023-08-08
4. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide;Epilepsy & Behavior;2023-08
5. Real-Life Efficacy and Tolerability of Lacosamide in Pediatric Patients Aged 4 Years or Older with Drug-Resistant Epilepsy;Annals of Child Neurology;2023-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3